Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients-Reference-Cited by-同舟云学术

Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients

Published:2009-01-29 Issue:1 Volume:93 Page:14-20
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Dupont E.,Andersen A.,Boas J.,Boisen E.,Borgmann R.,Helgetveit A. C.,Kjaer M. O.,Kristensen T. N.,Mikkelseng B.,Pakkenberg H.,Presthus J.,Stien R.,Worm-Petersen J.,Buch D.

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1996.tb00163.x/fullpdf

Reference30 articles.

1. On-off effects in patients with Parkinson's disease on chronic levodopa therapy;Marsden;Lancet,1916

2. Motor response complications and the function of striatal efferent systems;Chase;Neurology,1993

3. Clinical and pathophysiologic aspects of late levodopa failure;Poewe;Neurology,1993

4. On-off fluctuations in Parkinson's disease: a clinical and neuropharmacological study;Hardie;Brain,1984

5. Control of on-off phenomena by continuous intravenous infusion of levodopa;Quinn;Neurology,1984

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlled-Release Levodopa for the Treatment of Rapid Motor Fluctuations in Parkinson's Disease Subjects with Subthalamic Nucleus Deep Brain Stimulation;Asian Journal of Neurosurgery;2023-06

2. The risk of developing motor complications with Levodopa immediate versus dual release upon treatment initiation in Parkinson’s disease;Clinical Parkinsonism & Related Disorders;2023

3. The distorted body: The perception of the relative proportions of the body is preserved in Parkinson’s disease;Psychonomic Bulletin & Review;2022-04-20

4. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary;Neurology;2021-11-15

5. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease;Drug Metabolism and Personalized Therapy;2021-08-13